Vimarsana
Biggest News Aggregation in the World

Jon Koff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jon Koff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jon Koff Today - Breaking & Trending Today

Junior class council raffles meal with Salovey for cystic fibrosis fundraiser - Vimarsana News

Junior class council raffles meal with Salovey for cystic fibrosis fundraiser

Jackson Parrott ’27 will dine with Salovey — his prize for winning the junior class council’s fundraiser raffle for cystic fibrosis research.

Cystic Fibrosis Foundation Invests in Felix Biotechnology as They Advance New Therapies Targeting Chronic Infections in Cystic Fibrosis - Vimarsana News

Cystic Fibrosis Foundation Invests in Felix Biotechnology as They Advance New Therapies Targeting Chronic Infections in Cystic Fibrosis

/PRNewswire/ -- Felix Biotechnology — a biopharmaceutical company focused on developing first-in-class, durable, antibacterial therapies to treat chronic...

Cystic Fibrosis Foundation Invests in Felix Biotechnology as They Advance New Therapies Targeting Chronic Infections in Cystic Fibrosis - Vimarsana News

Cystic Fibrosis Foundation Invests in Felix Biotechnology as They Advance New Therapies Targeting Chronic Infections in Cystic Fibrosis

/PRNewswire/ -- Felix Biotechnology — a biopharmaceutical company focused on developing first-in-class, durable, antibacterial therapies to treat chronic...

New Yale Center to Advance Phage Understanding, Treatments, Training, Education - Vimarsana News

New Yale Center to Advance Phage Understanding, Treatments, Training, Education

The Center for Phage Biology and Therapy at Yale held its launch event on Thursday, January 27, 2022, by hosting a panel discussion on the context of the

Source: yale.edu
No Clinical Benefit Suggested by Addition of Pulmozyme® to Treatment of Critically Ill Patients With COVID-19 in I-SPY COVID Trial - Vimarsana News

No Clinical Benefit Suggested by Addition of Pulmozyme® to Treatment of Critically Ill Patients With COVID-19 in I-SPY COVID Trial

/PRNewswire/ -- Today Quantum Leap Healthcare Collaborative (QLHC), sponsor of the I-SPY COVID Trial, announced that the Pulmozyme® (dornase alfa) arm of the...